ReviewCellular oncology (Dordrecht, Netherlands)2022

Applications and mechanisms of the cyclin-dependent kinase 4/6 inhibitor, PD-0332991, in solid tumors.

Wenjian Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.